SCHEMBL30890758

SCHEMBL30890758

[2H]C1N(CCCC)CCC12Oc1cccc(C)c1NC2=O

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HTR4 Q13639 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890761 0.65 GAA (0.39) —
SCHEMBL11831487 0.62 SIGMAR1 (0.64) —
SCHEMBL18730487 0.60 SIGMAR1 (0.66) —
SCHEMBL9473185 0.59 SIGMAR1 (0.44) —
SCHEMBL31515402 0.59 PDE7A (0.38) —
SCHEMBL22695462 0.59 ALDH1A1 (0.39) —
SCHEMBL4133821 0.58 S1PR1 (0.39) —
SCHEMBL8576957 0.58 DRD2 (0.67) —
SCHEMBL3488166 0.58 NR3C2 (0.54) —
SCHEMBL7483409 0.58 CYP2D6 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback